Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of NKTR-118 for Opioid-Induced Constipation
2007-005421-30Phase 2Terminated
- Sponsor
- Nektar Therapeutics
- Start
- Dec 2007
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in opioid-induced constipation (OIC) comparing NKTR-118 arm with Placebo arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2007; status: terminated.
02
Drugs
naloxegol
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on 2007-005421-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005421-30.